Atea Pharmaceuticals, Inc. (AVIR)

Atea Pharmaceuticals, Inc. (AVIR) is a healthcare company (biotechnology) based in the United States. The share price is $4.07, down 1.33% on the day, which values the company at $326.44M. Price as of 17 Nov 2026, 17:30 UTC, from Yahoo Finance.

Key facts

Share price
$4.07−1.33% today
Market value
$326.44M
200-week average
$3.758% above
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Atea Pharmaceuticals, Inc. in more detail

AVIR trades at -3.0× next year's expected earnings. It sits 8% above its 200-week average of $3.75.

In its favour: More cash than debt. Worth checking: Weak Piotroski score.

Atea Pharmaceuticals, Inc. (AVIR): questions and answers

What is Atea Pharmaceuticals, Inc.'s market cap?

Atea Pharmaceuticals, Inc. is valued at $326.44M at a share price of $4.07.

Is AVIR above its 200-week moving average?

Yes. AVIR is 8.3% above its 200-week average of $3.75. Long-term investors watch that line because strong companies rarely trade below it for long.

Does AVIR pay a dividend?

Atea Pharmaceuticals, Inc. does not currently pay a regular dividend.

Cite this page

Funkfolio, “Atea Pharmaceuticals, Inc. (AVIR) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/AVIR

Underlying data: Yahoo Finance; company filings with the SEC.